SLS

Sellas Life Sciences Group I

NASDAQ · Biotechnology

$3.73

+0.20 (+5.67%)

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

7 analysts

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +808.8% upside

Low Target $25.20

Average Target $33.90

High Target $43.49

Current Price $3.73

Current
$3.73

Target
$33.90

$25.20 $33.90 avg $43.49